Get our daily coronavirus email newsletter with all the news you need to know direct to your inbox Sign up Thank you for subscribing We have more newsletters Show me See our privacy notice Invalid EmailThe hotly anticipated University of Oxford vaccine faces knock-on delays with its trials. A month-long pause in the jab's development could mean volunteers who had already been given one shot may not be able to get the planned second. The delay is due to American regulators investigating potential side effects, the Times reports. (Image: Getty Images)At the end of last week scientists working on the Oxford vaccine expressed hope that regulators could approve it before the beginning of 2021, The Times reported. The European Medicines Agency (EMA) said last Thursday it has started reviewing data on AstraZeneca and Oxford University's potential vaccine, in real time, the first of such moves aimed at speeding up any approval process in the region for a vaccine.

Source: Daily Mirror October 07, 2020 23:02 UTC